If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTPG.L Regulatory News (TPG)

  • There is currently no data for TPG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) (TP Group plc)

10 Nov 2022 07:00

RNS Number : 8827F
TP Group PLC
10 November 2022
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

TP Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

TP Group plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

9 November 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

 

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of 1p each in the capital of TP Group plc

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

 

Nil

 

(2) Cash-settled derivatives:

 

Nil

 

Nil

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

 

Nil

 

 

TOTAL:

Nil

 

Nil

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

Nil

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

a) Ordinary Shares of 1p each in the capital of TP Group plc held by Directors of TP Group plc and their close relatives:

 

Name

No. of Shares

% of Issued Share Capital

David Lindsay (Non-Executive Director)

2,600,000

0.33%

Derren Stroud (Chief Financial Officer)

653,847

0.08%

 

 

b) Options and awards granted under TP Group's share option scheme held by the directors of TP Group plc.

 

No directors of TP Group plc hold any options over ordinary shares in TP Group plc, nor any other rights to subscribe for new ordinary shares.

 

c) Interests or rights to subscribe held by connected advisers of TP Group plc

 

Cenkos Securities plc holds warrants to subscribe for new ordinary shares in TP Group plc:

 

Name

 

Warrant holder

Description of warrants

Number of warrants over new ordinary shares

Grant date

Lapse date

Exercise price

Cenkos Securities plc

Warrants to subscribe for new ordinary shares in TP Group plc

23,375,361

29 September 2021

29 September 2026

5.8p per share

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

10 November 2022

Contact name:

Derren Stroud, Chief Financial Officer and Company Secretary

 

Telephone number:

Tel: 01753 285802

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEEAKFNEFXAFFA
Date   Source Headline
20th Oct 20207:00 amRNSInterim Results
6th Oct 20207:00 amRNSAI system contract in the United States
22nd Sep 20201:43 pmRNSNotice of Results
17th Sep 20207:00 amRNSHydrogen fuelling partnership agreement
15th Sep 20207:00 amRNSAtmosphere management equipment orders
25th Aug 20207:00 amRNSAcquisition of Osprey Consulting Services Ltd
17th Aug 20207:00 amRNS£2m extension to MoD Consulting contract
5th Aug 20207:00 amRNSFramework contract with Eurocontrol
3rd Aug 20207:00 amRNSHydrogen system contract
21st Jul 20207:00 amRNSEUR9m work orders secured under ESA contract
16th Jul 202011:30 amRNSResult of AGM
16th Jul 20207:01 amRNSGreen Economy Mark
16th Jul 20207:00 amRNSTrading Update
25th Jun 20209:44 amRNSPosting of Annual Report and Notice of AGM
23rd Jun 20207:00 amRNSAI system contract in the UAE energy sector
18th Jun 20207:00 amRNSEUR18m work orders secured under ESA contract
8th Jun 20207:00 amRNSFirst production of oxygen from new modular system
29th May 20204:21 pmRNSHolding(s) in Company
21st May 20207:00 amRNSFinal Results for the year ending 31 December 2019
15th May 20204:09 pmRNSHolding(s) in Company
23rd Apr 202012:41 pmRNSAudit Update
16th Apr 20207:00 amRNSDevelopment of on-site medical gas production
24th Mar 20207:00 amRNSESA framework contract extension
17th Mar 20204:30 pmRNSRevised Date for Announcement of Year end Results
3rd Mar 20203:59 pmRNSFinance Facility
3rd Mar 202012:55 pmRNSHoldings in Company
27th Feb 20207:00 amRNSUK Defence Consulting Contract
27th Jan 20207:01 amRNSEuropean Contract for Rugged Military Servers
27th Jan 20207:00 amRNSTrading Update and Notice of Results
14th Jan 20205:04 pmRNSHolding(s) in Company
14th Jan 20207:00 amRNSSubmarine Oxygen Generating Devices Order
13th Jan 20205:18 pmRNSHolding(s) in Company
13th Jan 20205:04 pmRNSHolding(s) in Company
9th Jan 20207:00 amRNSSubmarine Carbon Dioxide System Contract
7th Jan 20207:00 amRNSESA Agreement for ECLIPSE Software Suite
22nd Oct 20194:41 pmRNSHolding(s) in Company
22nd Oct 20194:38 pmRNSHolding(s) in Company
7th Oct 20197:00 amRNSMilitary satellite communications contract
17th Sep 20197:00 amRNSOxygen generating equipment order
10th Sep 20197:00 amRNSInterim Results
15th Aug 20197:00 amRNSNotice of Results
16th Jul 20197:00 amRNSTrading Update
2nd Jul 20197:00 amRNSFurther investment in European AI systems company
6th Jun 201912:45 pmRNSResult of AGM
6th Jun 20197:00 amRNSAGM statement
3rd Jun 20197:00 amRNSNanotechnology licence agreement
8th May 20194:19 pmRNSHolding(s) in Company
1st May 20197:00 amRNSAcquisition of Sapienza Consulting Holding BV.
29th Apr 20197:00 amRNSDefence equipment contract
26th Apr 201911:15 amRNSHoldings in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.